SEHK:1548Life Sciences
Genscript Biotech Governance Reset Puts Shareholder Rights Under Fresh Focus
Genscript Biotech (SEHK:1548) has proposed amendments to its memorandum and articles of association.
The planned changes relate to the company’s core corporate governance framework and could influence shareholder rights and internal decision making.
For investors watching Genscript Biotech at a share price of HK$14.19, the move to adjust its foundational documents comes alongside mixed longer term share performance. The stock is up 6.6% over the past week, 33.9% over the past month, 10.9%...